Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics

Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,491 · see citing works

Concordance of the toxicity of pharmaceuticals in humans and in animals

Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · see citing works

WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013

Wang, J., Duncan, D. T., Shi, Z., & Zhang, B. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt439 · Cited by 1,502 · see citing works

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction

Martignoni, M., Groothuis, G. M. M., & de Kanter, R. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.6.875 · Cited by 1,478 · see citing works

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

Cook, D., Brown, D., Alexander, R., March, R., Morgan, P., Satterthwaite, G., & Pangalos, M. N. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4309 · Cited by 1,344 · see citing works

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739 · see citing works

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Onakpoya, I., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 617 · see citing works

Worldwide Distribution of Cytochrome P450 Alleles: A Meta‐analysis of Population‐scale Sequencing Projects

Zhou, Y., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.690 · Cited by 592 · see citing works

In vitro models for liver toxicity testing

Soldatow, V. Y., LeCluyse, E. L., Griffith, L. G., & Rusyn, I. (2012) · Toxicology Research · doi:10.1039/c2tx20051a · Cited by 482 · see citing works

Managing the challenge of chemically reactive metabolites in drug development

Park, B. K., Boobis, A. R., Clarke, S. E., Goldring, C. E., Jones, D., Kenna, J. G., Lambert, C., Laverty, H., Naisbitt, D. J., Nelson, S. D., et al. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3408 · Cited by 466 · see citing works

Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes

Laine, J., Auriola, S. O. K., Pasanen, M., & Juvonen, R. O. (2009) · Xenobiotica · doi:10.1080/00498250802512830 · Cited by 258 · see citing works

Hepatocyte polarity

Treyer, A., & Müsch, A. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120009 · Cited by 252 · see citing works

Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways

Bort, R., Macé, K., Boobis, A. R., Gómez‐Lechón, M. J., Pfeifer, A. C., & Castell, J. V. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00167-7 · Cited by 241 · see citing works

OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

Chen, L., Shu, Y., Liang, X., Chen, E. C., Yee, S. W., Zur, A. A., Li, S., Xu, L., Keshari, K. R., Lin, M. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314939111 · Cited by 234 · see citing works

Novel 3D Culture Systems for Studies of Human Liver Function and Assessments of the Hepatotoxicity of Drugs and Drug Candidates

Lauschke, V. M., Hendriks, D. F. G., Bell, C. C., Andersson, T. B., & Ingelman-Sundberg, M. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00150 · Cited by 226 · see citing works

Competency of different cell models to predict human hepatotoxic drugs

Gómez-Lechón, M. J., Tolosa, L., Conde, I., & Donato, M. T. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.967680 · Cited by 199 · see citing works

Transcriptional, Functional, and Mechanistic Comparisons of Stem Cell–Derived Hepatocytes, HepaRG Cells, and Three-Dimensional Human Hepatocyte Spheroids as Predictive In Vitro Systems for Drug-Induced Liver Injury

Bell, C. C., Lauschke, V. M., Vorrink, S. U., Palmgren, H., Duffin, R., Andersson, T. B., & Ingelman-Sundberg, M. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074369 · Cited by 189 · see citing works

Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics

Vorrink, S. U., Ullah, S., Schmidt, S., Nandania, J., Velagapudi, V., Beck, O., Ingelman‐Sundberg, M., & Lauschke, V. M. (2017) · The FASEB Journal · doi:10.1096/fj.201601375r · Cited by 172 · see citing works

Oxidation of Troglitazone to a Quinone-Type Metabolite Catalyzed by Cytochrome P-450 2C8 and P-450 3A4 in Human Liver Microsomes

Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F. P., & Yokoi, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14927-6 · Cited by 161 · see citing works

Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile

Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1694-y · Cited by 141 · see citing works

Reactive Metabolites: Current and Emerging Risk and Hazard Assessments

Thompson, R. A., Isin, E. M., Ogese, M. O., Mettetal, J. T., & Williams, D. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00410 · Cited by 141 · see citing works

Proteome-Wide Analyses of Human Hepatocytes During Differentiation and Dedifferentiation

Rowe, C., Gerrard, D. T., Jenkins, R., Berry, A., Durkin, K., Sundstrom, L., Goldring, C. E., Park, K. B., Kitteringham, N. R., Hanley, K. P., et al. (2013) · Hepatology · doi:10.1002/hep.26414 · Cited by 133 · see citing works

Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery

Ewart, L. C., Dehne, E., Fabre, K. M., Gibbs, S., Hickman, J. J., Hornberg, E., Ingelman‐Sundberg, M., Jang, K., Jones, D. R., Lauschke, V. M., et al. (2017) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052722 · Cited by 130 · see citing works

Sandwich-cultured hepatocytes: utility forin vitroexploration of hepatobiliary drug disposition and drug-induced hepatotoxicity

Bruyn, T. D., Chatterjee, S., Fattah, S., Keemink, J., Nicolaï, J., Augustijns, P., & Annaert, P. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.773973 · Cited by 124 · see citing works

High-Content Assays for Hepatotoxicity Using Induced Pluripotent Stem Cell–Derived Cells

Sirenko, O., Hesley, J., Rusyn, I., & Cromwell, E. F. (2013) · Assay and Drug Development Technologies · doi:10.1089/adt.2013.520 · Cited by 123 · see citing works

Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation

Lauschke, V. M., Vorrink, S. U., Moro, S. M. L., Rezayee, F., Nordling, Å., Hendriks, D. F. G., Bell, C. C., Sison‐Young, R., Park, B. K., Goldring, C. E., et al. (2016) · Hepatology · doi:10.1002/hep.28780 · Cited by 113 · see citing works

A multicenter assessment of single-cell models aligned to standard measures of cell health for prediction of acute hepatotoxicity

Sison-Young, R. L. C., Lauschke, V. M., Johann, E., Alexandre, E., Anthérieu, S., Aerts, H., Gerets, H. H. J., Labbe, G., Hoët, D., Dorau, M., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1745-4 · Cited by 105 · see citing works

Hepatocyte-based in vitro model for assessment of drug-induced cholestasis

Chatterjee, S., Richert, L., Augustijns, P., & Annaert, P. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.032 · Cited by 91 · see citing works

The Importance of Patient-Specific Factors for Hepatic Drug Response and Toxicity

Lauschke, V. M., & Ingelman‐Sundberg, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101714 · Cited by 90 · see citing works

Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells

Yamamoto, Y., Yamazaki, H., Ikeda, T., Watanabe, T., Iwabuchi, H., Nakajima, M., & Yokoi, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.155 · Cited by 82 · see citing works

Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues

Messner, S., Fredriksson, L., Lauschke, V. M., Roessger, K., Escher, C., Bober, M., Kelm, J. M., Ingelman‐Sundberg, M., & Moritz, W. (2017) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0022 · Cited by 77 · see citing works

Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes

Oorts, M., Baze, A., Bachellier, P., Heyd, B., Zacharias, T., Annaert, P., & Richert, L. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.03.008 · Cited by 61 · see citing works

Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis

Burbank, M., Burban, A., Sharanek, A., Weaver, R. J., Guguen‐Guillouzo, C., & Guillouzo, A. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071373 · Cited by 58 · see citing works

Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man

Dragović, S., Vermeulen, N. P. E., Gerets, H. H. J., Hewitt, P. G., Ingelman‐Sundberg, M., Park, B. K., Juhila, S., Snoeys, J., & Weaver, R. J. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1845-1 · Cited by 57 · see citing works

Inter-donor variability of phase I/phase II metabolism of three reference drugs in cryopreserved primary human hepatocytes in suspension and monolayer

den Braver-Sewradj, S. P., den Braver, M. W., Vermeulen, N. P. E., Commandeur, J. N. M., Richert, L., & Vos, J. C. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.02.013 · Cited by 53 · see citing works

Steady‐State Pharmacokinetics and Dose Proportionality of Troglitazone and Its Metabolites

Loi, C., Alvey, C. W., Vassos, A. B., Randinitis, E. J., Sedman, A. J., & Koup, J. R. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008533 · Cited by 53 · see citing works

Network Analysis of Primary Hepatocyte Dedifferentiation Using a Shotgun Proteomics Approach

Rowe, C., Goldring, C. E. P., Kitteringham, N. R., Jenkins, R. E., Lane, B. S., Sanderson, C., Elliott, V., Platt, V., Metcalfe, P., & Park, B. K. (2010) · Journal of Proteome Research · doi:10.1021/pr1001687 · Cited by 51 · see citing works

Kinetics and dynamics of cyclosporine A in three hepatic cell culture systems

Bellwon, P., Truisi, G. L., Bois, F. Y., Wilmes, A., Schmidt, T., Savary, C. C., Parmentier, C., Hewitt, P. G., Schmal, O., Jossé, R., et al. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.07.016 · Cited by 40 · see citing works

Evaluation of transcriptomic signature as a valuable tool to study drug-induced cholestasis in primary human hepatocytes

Parmentier, C., Couttet, P., Wolf, A., Zaccharias, T., Heyd, B., Bachellier, P., Uteng, M., & Richert, L. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1930-0 · Cited by 36 · see citing works

Bioavailability of two new formulations of paracetamol, compared with three marketed formulations, in healthy volunteers

Sevilla-Tirado, F. J., González-Vallejo, E. B., Leary, A. C., Breedt, H. J., Hyde, V. J., & Fernández-Hernando, N. (2003) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2003.25.7.778092 · Cited by 34 · see citing works

Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures

Parmentier, C., Truisi, G. L., Mönks, K., Stanzel, S. F., Lukas, A., Kopp‐Schneider, A., Alexandre, E., Hewitt, P. G., Mueller, S. O., & Richert, L. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.052415 · Cited by 34 · see citing works

Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats

Richert, L., Baze, A., Parmentier, C., Gerets, H. H. J., Sison-Young, R. L. C., Dorau, M., Lovatt, C. A., Czich, A., Goldring, C. E., Park, B. K., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.06.1127 · Cited by 25 · see citing works

Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers

Bowsher, R. R., Compton, J., Kirkwood, J. A., Place, G. D., Jones, C. D., Mabry, T. E., Hyslop, D. L., Hatcher, B. L., & DESANTE, K. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2134 · Cited by 22 · see citing works

Relative bioavailability of a newly developed pediatric formulation of bosentan vs. the adult formulation

Gutierrez, M. M., Nicolas, L. B., Donazzolo, Y., & Dingemanse, J. (2013) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cp201806 · Cited by 15 · see citing works

In vivo Bioequivalence of Oral Antidiabetic Agents: Pioglitazone Tablets

Wong, H., Özalp, Y., Lainesse, A., & Alpan, R. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1297059 · Cited by 15 · see citing works

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Weaver, R. J., Blomme, E. A. G., Chadwick, A. E., Copple, I. M., Gerets, H. H. J., Goldring, C. E., Guillouzo, A., Hewitt, P. G., Ingelman‐Sundberg, M., Jensen, K. G., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0048-x · Cited by 254 · see citing works

Engineering Multi‐Cellular Spheroids for Tissue Engineering and Regenerative Medicine

Kim, S., Kim, E. M., Yamamoto, M., Park, H., & Shin, H. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000608 · Cited by 233 · see citing works

3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration

Wang, H., Brown, P. C., Chow, E. C. Y., Ewart, L. C., Ferguson, S., Fitzpatrick, S., Freedman, B., Guo, G. L., Hedrich, W. D., Heyward, S. A., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.13066 · Cited by 219 · see citing works

A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®

Bircsak, K. M., DeBiasio, R., Miedel, M. T., Alsebahi, A., Reddinger, R. M., Saleh, A. D., Shun, T., Vernetti, L. A., & Gough, A. (2021) · Toxicology · doi:10.1016/j.tox.2020.152667 · Cited by 198 · see citing works

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions

Vorrink, S. U., Zhou, Y., Ingelman-Sundberg, M., & Lauschke, V. M. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy058 · Cited by 187 · see citing works

A Review of CYP-Mediated Drug Interactions: Mechanisms and In Vitro Drug-Drug Interaction Assessment

Lee, J., Beers, J. L., Geffert, R. M., & Jackson, K. D. (2024) · Biomolecules · doi:10.3390/biom14010099 · Cited by 177 · see citing works

Bioprinting of Multiscaled Hepatic Lobules within a Highly Vascularized Construct

Kang, D., Hong, G., An, S., Jang, I., Yun, W., Shim, J., & Jin, S. (2020) · Small · doi:10.1002/smll.201905505 · Cited by 164 · see citing works

In vitro and ex vivo models of adipocytes

Dufau, J., Shen, J. X., Couchet, M., Barbosa, T. D. C., Mejhert, N., Massier, L., Griseti, E., Mouisel, É., Amri, E., Lauschke, V. M., et al. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00519.2020 · Cited by 155 · see citing works

3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications

Lauschke, V. M., Shafagh, R. Z., Hendriks, D. F. G., & Ingelman‐Sundberg, M. (2019) · Biotechnology Journal · doi:10.1002/biot.201800347 · Cited by 135 · see citing works

A critical perspective on 3D liver models for drug metabolism and toxicology studies

Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138 · see citing works

Cell spheroids as a versatile research platform: formation mechanisms, high throughput production, characterization and applications

Decarli, M. C., do Amaral, R. L. F., dos Santos, D. P., Tofani, L. B., Katayama, E. T., Rezende, R. A., da Silva, J. V. L., Swiech, K., Suazo, C. A. T., Mota, C., et al. (2021) · Biofabrication · doi:10.1088/1758-5090/abe6f2 · Cited by 132 · see citing works

In Vitro Models for Non-Alcoholic Fatty Liver Disease: Emerging Platforms and Their Applications

Ramos, M. J., Bandiera, L., Menolascina, F., & Fallowfield, J. A. (2022) · iScience · doi:10.1016/j.isci.2021.103549 · Cited by 127 · see citing works

Predicting Drug-Induced Liver Injury with Bayesian Machine Learning

Williams, D. P., Lazic, S. E., Foster, A. J., Semenova, E., & Morgan, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00264 · Cited by 124 · see citing works

Today’s Challenges to De-Risk and Predict Drug Safety in Human “Mind-the-Gap”

Weaver, R. J., & Valentin, J. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy270 · Cited by 120 · see citing works

Individual Control and Quantification of 3D Spheroids in a High-Density Microfluidic Droplet Array

Tomasi, R. F.-X., Sart, S., Champetier, T., & Baroud, C. N. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107670 · Cited by 117 · see citing works

Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies

Norman, B. H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00524 · Cited by 119 · see citing works

Human in vitro models of nonalcoholic fatty liver disease

Müller, F. A., & Sturla, S. J. (2019) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2019.03.001 · Cited by 118 · see citing works

Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid

Foster, A. J., Chouhan, B., Regan, S. L., Rollison, H., Amberntsson, S., Andersson, L. C., Srivastava, A., Darnell, M., Cairns, J., Lazic, S. E., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02427-4 · Cited by 117 · see citing works

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection

Monteil, V., Dyczynski, M., Lauschke, V. M., Kwon, H., Wirnsberger, G., Youhanna, S. C., Zhang, H., Slutsky, A. S., del Pozo, C. H., Horn, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013426 · Cited by 96 · see citing works

Decellularized tissues as platforms for in vitro modeling of healthy and diseased tissues

McCrary, M. W., Bousalis, D., Mobini, S., Song, Y. H., & Schmidt, C. E. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.05.031 · Cited by 95 · see citing works

Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells

Baze, A., Parmentier, C., Hendriks, D. F. G., Hurrell, T., Heyd, B., Bachellier, P., Schuster, C., Ingelman‐Sundberg, M., & Richert, L. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0134 · Cited by 96 · see citing works

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development

Walker, P., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 93 · see citing works

Immune-mediated drug-induced liver injury: immunogenetics and experimental models

Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87 · see citing works

Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay

Mandon, M., Huet, S., Dubreil, E., Fessard, V., & Hégarat, L. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47114-7 · Cited by 87 · see citing works

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury

Zhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85 · see citing works

Drug metabolic stability in early drug discovery to develop potential lead compounds

Gajula, S. N. R., Nadimpalli, N., & Sonti, R. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1970178 · Cited by 83 · see citing works

Development of Cell Spheroids by Advanced Technologies

Shao, C., Chi, J., Zhang, H., Fan, Q., Zhao, Y., & Ye, F. (2020) · Advanced Materials Technologies · doi:10.1002/admt.202000183 · Cited by 76 · see citing works

Generation of uniform liver spheroids from human pluripotent stem cells for imaging-based drug toxicity analysis

Lee, G., Kim, H., Park, J. Y., Kim, G., Han, J., Chung, S. H., Yang, J. H., Jeon, J. S., Woo, D., Han, C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120529 · Cited by 78 · see citing works

Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip

Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 76 · see citing works

Evolution and impact of high content imaging.

Way, G. P., Sailem, H., Shave, S., Kasprowicz, R., & Carragher, N. O. (2023) · SLAS Discovery · doi:10.1016/j.slasd.2023.08.009 · Cited by 67 · see citing works

Towards improved hepatocyte cultures: Progress and limitations

Ruoß, M., Vosough, M., Königsrainer, A., Nadalin, S., Wagner, S., Sajadian, S., Huber, D., Heydari, Z., Ehnert, S., Hengstler, J. G., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111188 · Cited by 77 · see citing works

Three-Dimensional Spheroids With Primary Human Liver Cells and Differential Roles of Kupffer Cells in Drug-Induced Liver Injury

Li, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72 · see citing works

Generation and analysis of 3D cell culture models for drug discovery

Belfiore, L., Aghaei‐Ghareh‐Bolagh, B., Law, A. M. K., Dobrowolski, J. C., Raftery, L. J., Tjandra, A. D., Yee, C., Piloni, A., Volkerling, A. M., Ferris, C. J., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105876 · Cited by 74 · see citing works

Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system

Freyer, N., Knöspel, F., Damm, G., Greuel, S., Schneider, C., Seehofer, D., Stöhr, T., Petersen, K., & Zeilinger, K. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s186759 · Cited by 71 · see citing works

Recommended guidelines for developing, qualifying, and implementing complex in vitro models (CIVMs) for drug discovery

Ekert, J. E., Deakyne, J., Pribul-Allen, P., Terry, R., Schofield, C., Jeong, C. G., Storey, J., Mohamet, L., Francis, J., Naidoo, A., et al. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220923332 · Cited by 68 · see citing works

Artificial confocal microscopy for deep label-free imaging

Chen, X., Kandel, M. E., He, S., Hu, C., Lee, Y. J., Sullivan, K. M., Tracy, G., Chung, H. J., Kong, H. J., Anastasio, M. A., et al. (2023) · Nature Photonics · doi:10.1038/s41566-022-01140-6 · Cited by 67 · see citing works

Effects of PFAS on human liver transporters: implications for health outcomes

Vujic, E., Ferguson, S., & Brouwer, K. L. R. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae061 · Cited by 67 · see citing works

Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies

Kanebratt, K. P., Janefeldt, A., Vilén, L., Vildhede, A., Samuelsson, K., Milton, L., Björkbom, A., Persson, M., Leandersson, C., Andersson, T. B., et al. (2021) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.10.043 · Cited by 66 · see citing works

Engineering Liver Microtissues for Disease Modeling and Regenerative Medicine

Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65 · see citing works

Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements

Kaur, I., Vasudevan, A., Rawal, P., Tripathi, D. M., Ramakrishna, S., Kaur, S., & Sarin, S. K. (2023) · Bioengineering · doi:10.3390/bioengineering10020131 · Cited by 64 · see citing works

Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review

Nitsche, K. S., Müller, I. I., Malcomber, S., Carmichael, P. L., & Bouwmeester, H. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03234-0 · Cited by 66 · see citing works

Bioengineering Organs for Blood Detoxification

Legallais, C., Kim, D., Mihaila, S. M., Mihajlovic, M., Figliuzzi, M., Bonandrini, B., Salerno, S., Yengej, F. A. Y., Rookmaaker, M. B., Romero, N. S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800430 · Cited by 62 · see citing works

Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment

Hatherell, S., Baltazar, M. T., Reynolds, J., Carmichael, P. L., Dent, M. P., Li, H., Ryder, S., White, A., Walker, P., & Middleton, A. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa054 · Cited by 62 · see citing works

Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials

Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 64 · see citing works

In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells

Suurmond, C. E., Lasli, S., van den Dolder, F. W., Ung, A., Kim, H., Bandaru, P., Lee, K., Cho, H., Ahadian, S., Ashammakhi, N., et al. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901379 · Cited by 61 · see citing works

Hepatocyte organoids and cell transplantation: What the future holds

Peng, W. C., Kraaier, L. J., & Kluiver, T. A. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00579-x · Cited by 59 · see citing works

Advances in Engineered Human Liver Platforms for Drug Metabolism Studies

Underhill, G. H., & Khetani, S. R. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.083295 · Cited by 61 · see citing works

Three-Dimensional Liver Culture Systems to Maintain Primary Hepatic Properties for Toxicological Analysis In Vitro

Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59 · see citing works

Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three‐Dimensional Spheroid Cultures of Primary Human Hepatocytes

Hendriks, D. F. G., Vorrink, S. U., Smutny, T., Sim, S. C., Nordling, Å., Ullah, S., Kumondai, M., Jones, B. C., Johansson, I., Andersson, T. B., et al. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1860 · Cited by 57 · see citing works

3D human liver spheroids for translational pharmacology and toxicology

Ingelman‐Sundberg, M., & Lauschke, V. M. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13587 · Cited by 62 · see citing works

Generation of proliferating human adult hepatocytes using optimized 3D culture conditions

Rose, S., Ezan, F., Cuvellier, M., Bruyère, A., Legagneux, V., Langouët, S., & Baffet, G. (2021) · Scientific Reports · doi:10.1038/s41598-020-80019-4 · Cited by 58 · see citing works

Mechanisms and in vitro models of drug-induced cholestasis

Gijbels, E., Vilas‐Boas, V., Deferm, N., Devisscher, L., Jaeschke, H., Annaert, P., & Vinken, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02437-2 · Cited by 56 · see citing works

Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury

Cox, C. R., Lynch, S., Goldring, C. E., & Sharma, P. (2020) · Frontiers in Medical Technology · doi:10.3389/fmedt.2020.611913 · Cited by 57 · see citing works

Recent developments in in vitro and in vivo models for improved translation of preclinical pharmacokinetics and pharmacodynamics data

Yadav, J., Hassani, M. E., Sodhi, J. K., Lauschke, V. M., Hartman, J. H., & Russell, L. E. (2021) · Drug Metabolism Reviews · doi:10.1080/03602532.2021.1922435 · Cited by 57 · see citing works

Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development—Current State-of-the-Art and Future Perspectives

Youhanna, S. C., Kemas, A. M., Preiss, L. C., Zhou, Y., Shen, J. X., Cakal, S. D., Paqualini, F. S., Goparaju, S. K., Shafagh, R. Z., Lind, J. U., et al. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000238 · Cited by 57 · see citing works

Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models

D’Costa, K. A., Kosic, M., Lam, A., Moradipour, A., Zhao, Y., & Radisic, M. (2020) · Annals of Biomedical Engineering · doi:10.1007/s10439-020-02498-w · Cited by 54 · see citing works

High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability

Hiemstra, S. W., Ramaiahgari, S., Wink, S., Callegaro, G., Coonen, M. L. J., Meerman, J. H. N., Jennen, D. G. J., van den Nieuwendijk, K., Dankers, A. C. A., Snoeys, J., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02552-0 · Cited by 53 · see citing works

Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes

Luce, E., Messina, A., Duclos‐Vallée, J., & Dubart‐Kupperschmitt, A. (2021) · Hepatology · doi:10.1002/hep.31705 · Cited by 54 · see citing works

In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling

Romualdo, G., Leroy, K., Costa, C. J. S., Prata, G., Vanderborght, B., Silva, T. C. D., Barbisan, L. F., Andraus, W., Devisscher, L., Câmara, N., et al. (2021) · Cancers · doi:10.3390/cancers13215583 · Cited by 45 · see citing works

Bioengineered Pancreas–Liver Crosstalk in a Microfluidic Coculture Chip Identifies Human Metabolic Response Signatures in Prediabetic Hyperglycemia

Shafagh, R. Z., Youhanna, S. C., Keulen, J., Shen, J. X., Taebnia, N., Preiss, L. C., Klein, K., Büttner, F., Bergqvist, M., van der Wijngaart, W., et al. (2022) · Advanced Science · doi:10.1002/advs.202203368 · Cited by 51 · see citing works

3D Spheroid Primary Human Hepatocytes for Prediction of Cytochrome P450 and Drug Transporter Induction

Järvinen, E., Hammer, H., Poetz, O., Ingelman‐Sundberg, M., & Stage, T. B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2887 · Cited by 51 · see citing works

Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

Zhang, X. “., Jiang, T., Chen, D., Wang, Q., & Zhang, L. W. (2020) · Critical Reviews in Toxicology · doi:10.1080/10408444.2020.1756219 · Cited by 53 · see citing works

In Vitro Models for Studying Chronic Drug-Induced Liver Injury

Donato, M. T., Ferrer, G. G., & Tolosa, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911428 · Cited by 50 · see citing works

In Vitro Three‐Dimensional Liver Models for Nanomaterial DNA Damage Assessment

Llewellyn, S. V., Niemeijer, M., Nymark, P., Moné, M. J., van de Water, B., Conway, G. E., Jenkins, G. J. S., & Doak, S. H. (2021) · Small · doi:10.1002/smll.202006055 · Cited by 41 · see citing works

Current strategies with implementation of three-dimensional cell culture: the challenge of quantification

Temple, J., Velliou, E. G., Shehata, M., Lévy, R., & Gupta, P. (2022) · Interface Focus · doi:10.1098/rsfs.2022.0019 · Cited by 49 · see citing works

A review of hepatic nanotoxicology – summation of recent findings and considerations for the next generation of study designs

Kermanizadeh, A., Powell, L. G., & Stone, V. (2020) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2020.1751756 · Cited by 50 · see citing works

Application of In Vitro Metabolism Activation in High-Throughput Screening

Ooka, M., Lynch, C., & Xia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218182 · Cited by 49 · see citing works

Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics

Khairnar, R., Islam, M. A., Fleishman, J. S., & Kumar, S. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121185 · Cited by 46 · see citing works

Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations

Conway, G. E., Shah, U.-K., Llewellyn, S. V., Červená, T., Evans, S. J., Ali, A., Jenkins, G. J. S., Clift, M. J. D., & Doak, S. H. (2020) · Mutagenesis · doi:10.1093/mutage/geaa018 · Cited by 46 · see citing works

A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model

Kumar, M., Toprakhisar, B., Haele, M. V., Antoranz, A., Boon, R., Chesnais, F., Smedt, J. D., Tricot, T., Idoype, T. I., Canella, M., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121006 · Cited by 43 · see citing works

Multiscale modelling of drug transport and metabolism in liver spheroids

Leedale, J., Kyffin, J. A., Harding, A. L., Colley, H. E., Murdoch, C., Sharma, P., Williams, D. P., Webb, S. D., & Bearon, R. N. (2020) · Interface Focus · doi:10.1098/rsfs.2019.0041 · Cited by 44 · see citing works

A Standardized Collagen-Based Scaffold Improves Human Hepatocyte Shipment and Allows Metabolic Studies over 10 Days

Ruoß, M., Häussling, V., Schügner, F., Damink, L. H. H. O., Lee, S. M. L., Ge, L., Ehnert, S., & Nussler, A. K. (2018) · Bioengineering · doi:10.3390/bioengineering5040086 · Cited by 43 · see citing works

Microfluidic Multitissue Platform for Advanced Embryotoxicity Testing In Vitro

Boos, J. A., Misun, P. M., Michlmayr, A., Hierlemann, A. R., & Frey, O. (2019) · Advanced Science · doi:10.1002/advs.201900294 · Cited by 43 · see citing works

3D-bioprinted HepaRG cultures as a model for testing long term aflatoxin B1 toxicity in vitro

Schmidt, K., Berg, J., Röhrs, V., Kurreck, J., & Al‐Zeer, M. A. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.003 · Cited by 42 · see citing works

Chemical and biological assessments of environmental mixtures: A review of current trends, advances, and future perspectives

Luo, Y., Chen, Z., Hsieh, N., & Lin, T.-E. L. (2022) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2022.128658 · Cited by 43 · see citing works

Review of New Approach Methodologies for Application in Risk Assessment of Nanoparticles in the Food and Feed Sector: Status and Challenges

Usmani, S. M., Bremer‐Hoffmann, S., Cheyns, K., Cubadda, F., Dumit, V. I., Escher, S. E., Fessard, V., Gutleb, A. C., Léger, T., Liu, Y., et al. (2024) · EFSA Supporting Publications · doi:10.2903/sp.efsa.2024.en-8826 · Cited by 44 · see citing works

A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction

Bulutoglu, B., Rey-Bedón, C., Mert, S., Tian, L., Jang, Y.-Y., Yarmush, M. L., & Usta, O. B. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229106 · Cited by 41 · see citing works

Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for “Clinical Trials in a Dish”

Kumar, N., Sridharan, D., Palaniappan, A., Dougherty, J. A., Czirók, A., Isai, D. G., Mergaye, M., Angelos, M. G., Powell, H. M., & Khan, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.567842 · Cited by 42 · see citing works

In vitro and in silico liver models: Current trends, challenges and opportunities

Poloznikov, A. A. (2018) · ALTEX · doi:10.14573/altex.1803221 · Cited by 40 · see citing works

Fabrication of PNIPAm-based thermoresponsive hydrogel microwell arrays for tumor spheroid formation

Dhamecha, D. L., Le, D., Chakravarty, T., Perera, K. D. C., Dutta, A., & Menon, J. U. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112100 · Cited by 40 · see citing works

Application of microphysiological systems in biopharmaceutical research and development

Peterson, N. C., Mahalingaiah, P. K. S., Fullerton, A. M., & Piazza, M. (2020) · Lab on a Chip · doi:10.1039/c9lc00962k · Cited by 39 · see citing works

A 3D cell printing-fabricated HepG2 liver spheroid model for high-content <i>in situ</i> quantification of drug-induced liver toxicity

Hong, S., & Song, J. M. (2021) · Biomaterials Science · doi:10.1039/d1bm00749a · Cited by 39 · see citing works

Organoid-guided precision hepatology for metabolic liver disease

Osonoi, S., & Takebe, T. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.002 · Cited by 40 · see citing works

An integrated biomimetic array chip for high-throughput co-culture of liver and tumor microtissues for advanced anticancer bioactivity screening

Hou, Y., Ai, X., Zhao, L., Gao, Z., Wang, Y., Lu, Y., Tu, P., & Jiang, Y. (2020) · Lab on a Chip · doi:10.1039/d0lc00288g · Cited by 38 · see citing works

Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches

Hall, A., Chanteux, H., Ménochet, K., Ledecq, M., & Schulze, M. E. D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02245 · Cited by 38 · see citing works

Liver spheroids on chips as emerging platforms for drug screening

Huang, D., Zhang, X., Fu, X., Zu, Y., Sun, W., & Zhao, Y. (2021) · Engineered Regeneration · doi:10.1016/j.engreg.2021.10.003 · Cited by 36 · see citing works

Utility of Three-Dimensional Cultures of Primary Human Hepatocytes (Spheroids) as Pharmacokinetic Models

Mizoi, K., Arakawa, H., Yano, K., Koyama, S., Kojima, H., & Ogihara, T. (2020) · Biomedicines · doi:10.3390/biomedicines8100374 · Cited by 35 · see citing works

An integrated biomimetic array chip for establishment of collagen‐based 3D primary human hepatocyte model for prediction of clinical drug‐induced liver injury

Xiao, R., Lv, T., Tu, X., Li, P., Wang, T., Dong, H., Tu, P., & Ai, X. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27931 · Cited by 37 · see citing works

Liver-on-chips for drug discovery and development

Mehta, V., Karnam, G., & Madgula, V. L. M. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101143 · Cited by 40 · see citing works

Pharmacokinetics‐On‐a‐Chip: In Vitro Microphysiological Models for Emulating of Drugs ADME

Ramadan, Q., Fardous, R. S., Hazaymeh, R., Alshmmari, S. K., & Zourob, M. M. (2021) · Advanced Biology · doi:10.1002/adbi.202100775 · Cited by 36 · see citing works

3D bioprinting of dECM-incorporated hepatocyte spheroid for simultaneous promotion of cell-cell and -ECM interactions

Kim, M. K., Jeong, W., Jeon, S., & Kang, H.-W. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1305023 · Cited by 38 · see citing works

Induction of steatosis in primary human hepatocytes recapitulates key pathophysiological aspects of metabolic dysfunction-associated steatotic liver disease

Kwon, Y., Gottmann, P., Wang, S., Tissink, J. J., Motzler, K., Sekar, R., Albrecht, W., Cadenas, C., Hengstler, J. G., Schürmann, A., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.06.040 · Cited by 36 · see citing works

The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model

Kermanizadeh, A., Brown, D. M., Moritz, W., & Stone, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-43870-8 · Cited by 33 · see citing works

Understanding the impact of more realistic low-dose, prolonged engineered nanomaterial exposure on genotoxicity using 3D models of the human liver

Llewellyn, S. V., Conway, G. E., Zanoni, I., Jørgensen, A. K., Shah, U.-K., Seleci, D. A., Keller, J. G., Kim, J. W., Wohlleben, W., Jensen, K. A., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00938-w · Cited by 34 · see citing works

Primary hepatocytes and their cultures for the testing of drug-induced liver injury

Vilas‐Boas, V., Cooreman, A., Gijbels, E., Campenhout, R. V., Arnesdotter, E., Ballet, S., Annaert, P., Cogliati, B., & Vinken, M. (2018) · Advances in pharmacology · doi:10.1016/bs.apha.2018.08.001 · Cited by 33 · see citing works

Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications

Xu, Q. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.730008 · Cited by 33 · see citing works

Replacement Flame-Retardant 2-Ethylhexyldiphenyl Phosphate (EHDPP) Disrupts Hepatic Lipidome: Evidence from Human 3D Hepatospheroid Cell Culture

Negi, C. K., Gadara, D. C., Kohoutek, J., Bajard, L., Spáčil, Z., & Bláha, L. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.2c03998 · Cited by 32 · see citing works

Microphysiological systems in absorption, distribution, metabolism, and elimination sciences

Ness, K. P. V., Cesar, F., Yeung, C. K., Himmelfarb, J., & Kelly, E. J. (2021) · Clinical and Translational Science · doi:10.1111/cts.13132 · Cited by 31 · see citing works

Considerations from an international regulatory and pharmaceutical industry (IQ MPS affiliate) workshop on the standardization of complex in vitro models in drug development

Tomlinson, L., Ramsden, D., Leite, S. B., Beken, S., Bonzo, J. A., Brown, P., Candarlioglu, P. L., Chan, T. S., Chen, E., Choi, C. K., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202300131 · Cited by 33 · see citing works

Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing

Donoghue, L., Nguyen, K. T. V., Graham, C., & Sethu, P. (2021) · Micromachines · doi:10.3390/mi12020139 · Cited by 31 · see citing works

Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease

Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739 · see citing works

Functional Comparison of HepaRG Cells and Primary Human Hepatocytes in Sandwich and Spheroid Culture as Repeated-Exposure Models for Hepatotoxicity

Li, J., Settivari, R. S., LeBaron, M. J., & Marty, M. S. (2019) · Applied In Vitro Toxicology · doi:10.1089/aivt.2019.0008 · Cited by 10 · see citing works

A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies

Ramaiahgari, S., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1215-9 · Cited by 363 · see citing works

Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures

Vorrink, S. U., Zhou, Y., Ingelman‐Sundberg, M., & Lauschke, V. M. (2018) · Proceedings for Annual Meeting of The Japanese Pharmacological Society · doi:10.1254/jpssuppl.wcp2018.0_po4-9-16

Hepatic Spheroids for Long-Term Toxicity Studies

Jakubek, L. M., Ulinski, G., Leite, D., Slavsky, M., Rajanna, S., Morelli, J. K., Kelly, M., Dwyer, J., Fitzgerald, M., Piepenhagen, P. A., et al. (2016) · Applied In Vitro Toxicology · doi:10.1089/aivt.2016.0016 · Cited by 5 · see citing works